Meyer Matthias R, Fredette Natalie C, Barton Matthias, Prossnitz Eric R
Department of Cell Biology and Physiology, University of New Mexico Health Sciences Center, Albuquerque, NM, United States.
Molecular Internal Medicine, University of Zürich, Zürich, Switzerland.
Life Sci. 2014 Nov 24;118(2):213-8. doi: 10.1016/j.lfs.2014.02.027. Epub 2014 Mar 5.
Aging is a major risk factor for carotid artery disease and stroke. Endothelin-1 (ET-1) and angiotensin II (Ang II) are important modifiers of vascular disease, partly through increased activity of NADPH oxidase and vasoconstrictor prostanoids. Since the renin-angiotensin and endothelin systems become activated with age, we hypothesized that aging affects NADPH oxidase- and prostanoid-dependent contractions to ET-1 and Ang II.
Carotid artery rings of young (4 month-old) and old (24 month-old) C57BL6 mice were pretreated with the NO synthase inhibitor L-NAME to exclude differential effects of NO. Contractions to ET-1 and Ang II were determined in the presence and absence of the NADPH oxidase-selective inhibitor gp91ds-tat or the thromboxane-prostanoid receptor antagonist SQ 29,548. Gene expression of endothelin and angiotensin receptors was measured by qPCR.
Aging reduced ET-1-induced contractions and diminished ETA but increased ETB receptor gene expression levels. Gp91ds-tat inhibited contractions to ET-1 in young and to a greater extent in old animals, whereas SQ 29,548 had no effect. Ang II-induced contractions were weak compared to ET-1 and unaffected by aging, gp91ds-tat, and SQ 29,548. Aging had also no effect on AT1A and AT1B receptor gene expression levels.
Aging in carotid arteries decreases ETA receptor gene expression and responsiveness to ET-1, which nevertheless becomes increasingly dependent upon NAPDH oxidase activity with age; responses to Ang II and gene expression of its receptors are however unaffected. These findings suggest that physiological aging differentially regulates functional responses to G protein-coupled receptor agonists and the signaling pathways associated with their activation.
衰老为颈动脉疾病和中风的主要风险因素。内皮素-1(ET-1)和血管紧张素II(Ang II)是血管疾病的重要调节因子,部分是通过增加NADPH氧化酶和血管收缩前列腺素的活性来实现。由于肾素-血管紧张素和内皮素系统会随着年龄增长而被激活,我们推测衰老会影响对ET-1和Ang II的NADPH氧化酶依赖性和前列腺素依赖性收缩。
用一氧化氮合酶抑制剂L-NAME预处理年轻(4月龄)和老年(24月龄)C57BL6小鼠的颈动脉环,以排除一氧化氮的不同影响。在存在和不存在NADPH氧化酶选择性抑制剂gp91ds-tat或血栓素-前列腺素受体拮抗剂SQ 29548的情况下,测定对ET-1和Ang II的收缩反应。通过定量PCR测量内皮素和血管紧张素受体的基因表达。
衰老减少了ET-1诱导的收缩,并降低了ETA但增加了ETB受体基因表达水平。Gp91ds-tat抑制年轻动物对ET-1的收缩,对老年动物的抑制作用更大,而SQ 29548则无作用。与ET-1相比,Ang II诱导的收缩较弱,且不受衰老、gp91ds-tat和SQ 29548的影响。衰老对AT1A和AT1B受体基因表达水平也无影响。
颈动脉衰老会降低ETA受体基因表达和对ET-1的反应性,不过随着年龄增长,其对ET-1的反应性越来越依赖于NAPDH氧化酶活性;然而,对Ang II的反应及其受体的基因表达不受影响。这些发现表明,生理性衰老对G蛋白偶联受体激动剂的功能反应及其激活相关信号通路的调节存在差异。